AI healthcare tech startup Signos expands partnership with Dexcom
Signs combines a wearable glucose monitor with an app powered by artificial intelligence. Source: Signs Health technology startup Signos announced…
Signs combines a wearable glucose monitor with an app powered by artificial intelligence. Source: Signs Health technology startup Signos announced…
Eli Lilly on Thursday said its next-generation drug passed a crucial late-stage trial in obese patients, achieving significant weight loss…
President Donald Trump speaks to introduce the TrumpRx website in the South Court Auditorium of the White House in Washington,…
A Wegovy injection pen is shown in Waterbury, Vermont, on April 28, 2025. Shelby Knowles | Bloomberg | fake images…
Nordisk is looking for deals more than ever, the Danish drugmaker's CEO said Wednesday in an interview with CNBC. “If…
Eli Lilly on Thursday reported first-quarter earnings and revenue that beat estimates and raised its full-year sales outlook by $2…
Obesity drug giant Eli Lilly reported a monster first quarter on Thursday, strengthening our conviction to hold the stock after…
When Branneisha Cooper began receiving the GLP-1 injection in Mounjaro in late 2022, she heard online that she could experience…
A UnitedHealthcare sign is displayed on its office building in Minnetonka, Minnesota, U.S., on Dec. 11, 2025. Tim Evans |…
Amazon GLP-1 Treatment Source: Amazon Inc. Amazon is delving into the burgeoning weight loss market, unveiling a new program Tuesday…